These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6075279)

  • 1. [Studies on the biotransformation of drugs and its significance in pharmaceutical industry].
    Hansen T
    Nord Med; 1967 Nov; 78(47):1549-54. PubMed ID: 6075279
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug metabolism: an industrial research view of the future.
    Ober RE
    Drug Metab Rev; 1979; 10(2):315-9. PubMed ID: 551917
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
    Baillie TA
    Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cultured hepatocytes and drugs].
    Bourel M; Guillouzo A; Ratanasavanh M; Chesne C; Guguen Guillouzo C
    C R Seances Soc Biol Fil; 1990; 184(3-4):211-6. PubMed ID: 2151313
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of metabolic activation in drug toxicity.
    Hinson JA; Pumford NR; Nelson SD
    Drug Metab Rev; 1994; 26(1-2):395-412. PubMed ID: 7521825
    [No Abstract]   [Full Text] [Related]  

  • 6. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preclinical investigation and testing of nontoxicity of drugs in the pharmaceutrial industry].
    Tripod J
    Schweiz Med Wochenschr; 1968 Aug; 98(31):1152-8. PubMed ID: 4236567
    [No Abstract]   [Full Text] [Related]  

  • 8. [The biotransformation of drugs in animals and in humans].
    Sanen FJ; Hong E
    Prensa Med Mex; 1969; 34(1):14-8. PubMed ID: 5787500
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current problems in drug research].
    Nuhn P
    Pharmazie; 1985 Jan; 40(1):1-9. PubMed ID: 3887436
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiological and toxicological aspects of metabolic activation of drugs].
    Szukalski B
    Acta Physiol Pol; 1984; 35 Suppl 27():36-81. PubMed ID: 6100809
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drugs: their development, safety, and effectiveness].
    Med Monatsschr; 1975 Sep; 29(9):385-6. PubMed ID: 1186596
    [No Abstract]   [Full Text] [Related]  

  • 12. [The biochemistry of toxic effects].
    Jacyszyn K
    Folia Med Cracov; 1987; 28(1-2):47-60. PubMed ID: 3623325
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicity testing in the 21st century: a view from the pharmaceutical industry.
    MacDonald JS; Robertson RT
    Toxicol Sci; 2009 Jul; 110(1):40-6. PubMed ID: 19435982
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of toxic pathways of metabolism by deuterium substitution.
    Pohl LR; Gillette JR
    Drug Metab Rev; 1984-1985; 15(7):1335-51. PubMed ID: 6398777
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmaceutical industry--to whom is it accountable?
    Hayes TA
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183881
    [No Abstract]   [Full Text] [Related]  

  • 16. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.
    Evans DC; Watt AP; Nicoll-Griffith DA; Baillie TA
    Chem Res Toxicol; 2004 Jan; 17(1):3-16. PubMed ID: 14727914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is post-marketing drug follow-up research or advertising?
    Weiss GB; Winslade WJ
    IRB; 1987; 9(4):10-1. PubMed ID: 11649947
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.